SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 178.24 |
Enterprise Value ($M) | 159.71 |
Book Value ($M) | 9.71 |
Book Value / Share | 0.42 |
Price / Book | 18.35 |
NCAV ($M) | 9.71 |
NCAV / Share | 0.42 |
Price / NCAV | 18.35 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.96 |
Return on Assets (ROA) | -0.99 |
Return on Equity (ROE) | -1.56 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 2.09 |
Current Ratio | 2.09 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 18.61 |
Assets | 18.61 |
Liabilities | 8.89 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -19.85 |
Net Income | -19.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -12.25 |
Cash from Investing | 0.00 |
Cash from Financing | 11.65 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Pontifax Management 4 G.p. (2015) Ltd. | 1.50 | -68.51 | |
13G/A | Mosseri Marlio Charles | 15.00 | 9.03 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
27,917 | 84,304 | 33.11 | |
44,381 | 164,157 | 27.04 | |
22,543 | 81,533 | 27.65 | |
28,205 | 87,487 | 32.24 | |
(click for more detail) |
Similar Companies | |
---|---|
NLSP – NLS Pharmaceutics AG | NRSN – NeuroSense Therapeutics Ltd. |
NRXP – NRx Pharmaceuticals, Inc. | OCEA – Ocean Biomedical, Inc. |
OCGN – Ocugen, Inc. |
Financial data and stock pages provided by
Fintel.io